ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Five Group Chairs Discuss Mergers In A Q&A

March 11, 2011

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981